Kim Sunoh, Kim Taehyun, Ahn Kwangseog, Park Woo-Kyu, Nah Seung-Yeol, Rhim Hyewhon
Biomedical Research Center, Korea Institute of Science and Technology (KIST), Seoul 136-791, Republic of Korea.
Biochem Biophys Res Commun. 2004 Oct 15;323(2):416-24. doi: 10.1016/j.bbrc.2004.08.106.
We previously reported that ginseng, a well-known herbal medicine, inhibited NMDA receptors in cultured hippocampal neurons. Here, we further examined the detailed mechanism of ginseng-mediated inhibition using its main active ingredient, ginsenoside Rg3. Co-application of ginsenoside Rg3 with increasing concentrations of NMDA did not change the EC50 of NMDA to the receptor, suggesting that ginsenoside Rg3 inhibits NMDA receptors without competing with the NMDA-binding site. Ginsenoside Rg3-mediated inhibition also occurred in a distinctive manner from the well-characterized NMDA receptor open channel blocker, MK-801. However, ginsenoside Rg3 produced its effect in a glycine concentration-dependent manner and shifted the glycine concentration-response curve to the right without changing the maximal response, suggesting the role of ginsenoside Rg3 as a competitive NMDA receptor antagonist. We also demonstrated that ginsenoside Rg3 significantly protected neurons against NMDA insults. Therefore, these results suggest that ginsenoside Rg3 protects NMDA-induced neuronal death via a competitive interaction with the glycine-binding site of NMDA receptors in cultured hippocampal neurons.
我们之前报道过,人参这种著名的草药可抑制培养的海马神经元中的NMDA受体。在此,我们使用其主要活性成分人参皂苷Rg3进一步研究了人参介导的抑制作用的详细机制。将人参皂苷Rg3与浓度不断增加的NMDA共同应用,并未改变NMDA对该受体的半数有效浓度(EC50),这表明人参皂苷Rg3抑制NMDA受体时不与NMDA结合位点竞争。人参皂苷Rg3介导的抑制作用也以一种与特征明确的NMDA受体开放通道阻滞剂MK-801不同的方式发生。然而,人参皂苷Rg3以甘氨酸浓度依赖性方式产生作用,使甘氨酸浓度-反应曲线右移但不改变最大反应,这表明人参皂苷Rg3作为竞争性NMDA受体拮抗剂发挥作用。我们还证明了人参皂苷Rg3能显著保护神经元免受NMDA损伤。因此,这些结果表明人参皂苷Rg3通过与培养的海马神经元中NMDA受体的甘氨酸结合位点竞争性相互作用来保护NMDA诱导的神经元死亡。